Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × tislelizumab × Clear all

NCT05531123 2024-07-12

Risk-stratification Based Bladder-sparing Modalities for Muscle-invasive Bladder Cancer

Phase 2 Recruiting

Urinary Bladder Neoplasms

NCT05445648 2022-12-28

CBPTMI

Phase 2 Unknown

Urinary Bladder Neoplasms